Healthcare -
Biotechnology - NASDAQ - US
$ 4.01
-2.44 %
$ 228 M
Market Cap
-4.04
P/E
DSGN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities DSGN - Design Therapeutics, Inc.
513 K
LAST VALUE
4572.24%
2 YEAR CAGR
21.22%
5 YEAR CAGR
0.00%
10 YEAR CAGR